• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MCRS1 通过与 Pkmyt1 蛋白激酶相互作用对胃癌细胞增殖、迁移、侵袭和上皮间质转化的影响。

Effects of MCRS1 on proliferation, migration, invasion, and epithelial mesenchymal transition of gastric cancer cells by interacting with Pkmyt1 protein kinase.

机构信息

Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Jinzhou Medical University, 3 Songpo Road, Jinzhou, Liaoning Province 121000, PR China.

Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Jinzhou Medical University, 3 Songpo Road, Jinzhou, Liaoning Province 121000, PR China.

出版信息

Cell Signal. 2019 Jul;59:171-181. doi: 10.1016/j.cellsig.2019.04.002. Epub 2019 Apr 3.

DOI:10.1016/j.cellsig.2019.04.002
PMID:30953699
Abstract

Microspherule protein 1(MCRS1) is known to be an oncogene in several tumors. However, recent studies have shown that MCRS1 inhibits lymphatic metastasis in gastric cancer (GC) patients by inhibiting telomerase activity. Protein kinase, membrane associated tyrosine/threonine 1(Pkmyt1), a member of the WEE1 family, has been found to interact with MCRS1 by yeast two-hybrid assay; however, how these two proteins interact in GC is still unclear. Hence, this study aimed to investigate the effect of MCRS1 interaction with Pkmyt1 on GC cell proliferation, migration, and invasion. Initially, we observed increased expression of MCRS1 in GC SGC-7901 cells and decreased expression in GC BGC-823 cells. Hence, we down-regulated MCRS1 expression in SGC-7901 cells and up-regulated it in BGC-823 cells. Our results showed that overexpression of MCRS1 inhibits the growth, invasion and migration of GC cells, while downregulation of MCRS1 promotes the growth, invasion and migration of GC cells. When MK1775, an inhibitor of WEE1 kinase, was added after downregulation of MCRS1, phenotypic recovery effects were observed. Overexpression of MCRS1 also inhibited the expression of Pkmyt1 and vice versa. This indicated that there might be a possible interaction between MCRS1 and Pkmyt1. Furthermore, immunoprecipitation assay revealed the interaction between MCRS1 and Pkmyt1 in virto, and immunofluorescence experiments showed that the two proteins were co-localized in the cytoplasm. In conclusion, our study confirmed the specific tumor suppressive activity of MCRS1 in GC proliferation, invasion and migration and suggested that it might inhibit the progression of GC through its interaction with Pkmyt1.

摘要

微球体蛋白 1(MCRS1)在几种肿瘤中被认为是一种癌基因。然而,最近的研究表明,MCRS1 通过抑制端粒酶活性抑制胃癌(GC)患者的淋巴转移。蛋白激酶,膜相关酪氨酸/苏氨酸 1(Pkmyt1),WEE1 家族的一员,已通过酵母双杂交试验发现与 MCRS1 相互作用;然而,这两种蛋白质在 GC 中的相互作用仍不清楚。因此,本研究旨在探讨 MCRS1 与 Pkmyt1 相互作用对 GC 细胞增殖、迁移和侵袭的影响。最初,我们观察到 MCRS1 在 GC SGC-7901 细胞中的表达增加,在 GC BGC-823 细胞中的表达减少。因此,我们下调了 SGC-7901 细胞中的 MCRS1 表达,并上调了 BGC-823 细胞中的 MCRS1 表达。结果表明,过表达 MCRS1 抑制 GC 细胞的生长、侵袭和迁移,而下调 MCRS1 促进 GC 细胞的生长、侵袭和迁移。在用 WEE1 激酶抑制剂 MK1775 下调 MCRS1 后添加时,观察到表型恢复效应。过表达 MCRS1 还抑制了 Pkmyt1 的表达,反之亦然。这表明 MCRS1 和 Pkmyt1 之间可能存在相互作用。此外,免疫沉淀试验显示了 MCRS1 和 Pkmyt1 在体外的相互作用,免疫荧光实验显示这两种蛋白质在细胞质中共定位。总之,我们的研究证实了 MCRS1 在 GC 增殖、侵袭和迁移中的特定肿瘤抑制活性,并表明它可能通过与 Pkmyt1 的相互作用抑制 GC 的进展。

相似文献

1
Effects of MCRS1 on proliferation, migration, invasion, and epithelial mesenchymal transition of gastric cancer cells by interacting with Pkmyt1 protein kinase.MCRS1 通过与 Pkmyt1 蛋白激酶相互作用对胃癌细胞增殖、迁移、侵袭和上皮间质转化的影响。
Cell Signal. 2019 Jul;59:171-181. doi: 10.1016/j.cellsig.2019.04.002. Epub 2019 Apr 3.
2
Overexpression of PKMYT1 indicates the poor prognosis and enhances proliferation and tumorigenesis in non-small cell lung cancer via activation of Notch signal pathway.PKMYT1的过表达预示着预后不良,并通过激活Notch信号通路增强非小细胞肺癌的增殖和肿瘤发生。
Eur Rev Med Pharmacol Sci. 2019 May;23(10):4210-4219. doi: 10.26355/eurrev_201905_17925.
3
PKMYT1 Promotes Epithelial-Mesenchymal Transition Process in Triple-Negative Breast Cancer by Activating Notch Signaling.PKMYT1 通过激活 Notch 信号促进三阴性乳腺癌中的上皮-间充质转化过程。
Rev Invest Clin. 2024;76(1):45-59. doi: 10.24875/RIC.23000256.
4
Protein kinase, membrane‑associated tyrosine/threonine 1 is associated with the progression of colorectal cancer.蛋白激酶,膜相关酪氨酸/苏氨酸 1 与结直肠癌的进展相关。
Oncol Rep. 2018 Jun;39(6):2829-2836. doi: 10.3892/or.2018.6371. Epub 2018 Apr 13.
5
Transcription factor TEAD4 facilitates glycolysis and proliferation of gastric cancer cells by activating PKMYT1.转录因子 TEAD4 通过激活 PKMYT1 促进胃癌细胞的糖酵解和增殖。
Mol Cell Probes. 2023 Dec;72:101932. doi: 10.1016/j.mcp.2023.101932. Epub 2023 Nov 2.
6
Demethylase ALKBH5 suppresses invasion of gastric cancer via PKMYT1 m6A modification.去甲基酶 ALKBH5 通过 PKMYT1 m6A 修饰抑制胃癌的侵袭。
Mol Cancer. 2022 Feb 3;21(1):34. doi: 10.1186/s12943-022-01522-y.
7
Suppression of BMX-ARHGAP fusion gene inhibits epithelial-mesenchymal transition in gastric cancer cells via RhoA-mediated blockade of JAK/STAT axis.抑制 BMX-ARHGAP 融合基因通过 RhoA 介导的 JAK/STAT 轴阻断抑制胃癌细胞的上皮-间充质转化。
J Cell Biochem. 2019 Jan;120(1):439-451. doi: 10.1002/jcb.27400. Epub 2018 Sep 14.
8
PKMYT1 promoted the growth and motility of hepatocellular carcinoma cells by activating beta-catenin/TCF signaling.PKMYT1通过激活β-连环蛋白/TCF信号通路促进肝癌细胞的生长和运动。
Exp Cell Res. 2017 Sep 15;358(2):209-216. doi: 10.1016/j.yexcr.2017.06.014. Epub 2017 Jun 23.
9
PKMYT1 inhibits lung adenocarcinoma progression by abrogating AKT1 activity.PKMYT1通过消除AKT1活性来抑制肺腺癌进展。
Cell Oncol (Dordr). 2023 Feb;46(1):195-209. doi: 10.1007/s13402-022-00744-y. Epub 2022 Nov 9.
10
Metastasis suppressor protein 1 regulated by PTEN suppresses invasion, migration, and EMT of gastric carcinoma by inactivating PI3K/AKT signaling.抑瘤转移蛋白 1 通过抑制 PTEN 激活 PI3K/AKT 信号通路抑制胃癌侵袭、迁移和 EMT。
J Cell Biochem. 2019 Mar;120(3):3447-3454. doi: 10.1002/jcb.27618. Epub 2018 Sep 23.

引用本文的文献

1
Meisoindigo Acts as a Molecular Glue to Target PKMYT1 for Degradation in Chronic Myeloid Leukemia Therapy.美索靛蓝作为一种分子胶靶向PKMYT1以在慢性髓性白血病治疗中促进其降解。
Adv Sci (Weinh). 2025 Jun;12(21):e2413676. doi: 10.1002/advs.202413676. Epub 2025 Apr 25.
2
Prognostic Significance of DNAJB4 Expression in Gastric Cancer: Correlation with CD31, Caspase-3, and Tumor Progression.DNAJB4表达在胃癌中的预后意义:与CD31、半胱天冬酶-3及肿瘤进展的相关性
Diagnostics (Basel). 2025 Mar 7;15(6):652. doi: 10.3390/diagnostics15060652.
3
WEE Family Kinase Inhibitors Combined with Sorafenib Can Selectively Inhibit HCC Cell Proliferation.
WEE家族激酶抑制剂与索拉非尼联合可选择性抑制肝癌细胞增殖。
Curr Cancer Drug Targets. 2025;25(4):370-385. doi: 10.2174/0115680096298370240520093003.
4
CKS1B as a potential target for prognostic assessment and intervention in pancreatic cancer and its role in abnormal proliferation and cellular phenotype through mediation of cell cycle signaling pathways.CKS1B作为胰腺癌预后评估和干预的潜在靶点及其通过介导细胞周期信号通路在异常增殖和细胞表型中的作用。
Saudi Med J. 2024 Feb;45(2):128-138. doi: 10.15537/smj.2024.45.2.20230132.
5
Unveiling promising breast cancer biomarkers: an integrative approach combining bioinformatics analysis and experimental verification.揭示有前途的乳腺癌生物标志物:结合生物信息学分析和实验验证的综合方法。
BMC Cancer. 2024 Jan 31;24(1):155. doi: 10.1186/s12885-024-11913-7.
6
The molecular characteristics and functional roles of microspherule protein 1 (MCRS1) in gene expression, cell proliferation, and organismic development.微球体蛋白 1(MCRS1)在基因表达、细胞增殖和机体发育中的分子特征和功能作用。
Cell Cycle. 2023 Mar-Mar;22(6):619-632. doi: 10.1080/15384101.2022.2145816. Epub 2022 Nov 16.
7
MCRS1 Expression Regulates Tumor Activity and Affects Survival Probability of Patients with Gastric Cancer.MCRS1表达调控肿瘤活性并影响胃癌患者的生存概率。
Diagnostics (Basel). 2022 Jun 20;12(6):1502. doi: 10.3390/diagnostics12061502.
8
c-Myb-mediated inhibition of miR-601 in facilitating malignance of osteosarcoma via augmentation of PKMYT1.c-Myb 介导的 miR-601 抑制通过增强 PKMYT1 促进骨肉瘤的恶性转化。
Sci Rep. 2022 Apr 23;12(1):6692. doi: 10.1038/s41598-022-10684-0.
9
Demethylase ALKBH5 suppresses invasion of gastric cancer via PKMYT1 m6A modification.去甲基酶 ALKBH5 通过 PKMYT1 m6A 修饰抑制胃癌的侵袭。
Mol Cancer. 2022 Feb 3;21(1):34. doi: 10.1186/s12943-022-01522-y.
10
PKMYT1, exacerbating the progression of clear cell renal cell carcinoma, is implied as a biomarker for the diagnosis and prognosis.PKMYT1 加剧透明细胞肾细胞癌的进展,被暗示作为诊断和预后的生物标志物。
Aging (Albany NY). 2021 Dec 27;13(24):25778-25798. doi: 10.18632/aging.203759.